A new antibiotic able to kill drug-resistant bacteria proves to be safe and effective in a phase II clinical trial, offering fresh hope in a global crisis.
A new antibiotic able to kill drug-resistant bacteria proves to be safe and effective in a phase II clinical trial, offering fresh hope in a global crisis.